Methotrexate should only be prescribed in 2.5mg tablets to avoid accidental overdose. How often this is safety guidance breached? Very often So we made a paper, AND A TOOL for every practice to use to spot how they can improve. https://t.co/566I0On3RA
RT @openprescribing: Our new paper is out today in @bjgp looking at unsafe prescribing of methotrexate, where higher doses can lead to toxi…
RT @sebbacon: New paper: we examine one drug where, 14 years after guidance was issued, dosing errors with potentially fatal consequences (…
RT @alexjohnwalker: Our newest OpenPrescribing paper describes unsafe prescribing of methotrexate. Prescribing of 10mg tablets is against a…
An important medication safety paper from our work on @openprescribing
RT @openprescribing: Our new paper is out today in @bjgp looking at unsafe prescribing of methotrexate, where higher doses can lead to toxi…
RT @openprescribing: Our new paper is out today in @bjgp looking at unsafe prescribing of methotrexate, where higher doses can lead to toxi…
RT @openprescribing: Our new paper is out today in @bjgp looking at unsafe prescribing of methotrexate, where higher doses can lead to toxi…
RT @openprescribing: Our new paper is out today in @bjgp looking at unsafe prescribing of methotrexate, where higher doses can lead to toxi…
Our new paper is out today in @bjgp looking at unsafe prescribing of methotrexate, where higher doses can lead to toxicity, poisoning and death https://t.co/E2L1wiulDZ
Our newest OpenPrescribing paper describes unsafe prescribing of methotrexate. Prescribing of 10mg tablets is against a 2006 safety recommendation. Although unsafe prescribing has reduced, 3.4% of prescriptions are still for 10mg tablets. https://t.co/vJga
RT @sebbacon: New paper: we examine one drug where, 14 years after guidance was issued, dosing errors with potentially fatal consequences (…
RT @sebbacon: New paper: we examine one drug where, 14 years after guidance was issued, dosing errors with potentially fatal consequences (…
New paper: we examine one drug where, 14 years after guidance was issued, dosing errors with potentially fatal consequences ("never events") still happen regularly in England. We argue for systematic audit and targetted research in GP alerts and outcomes h